NASDAQ
Camtek Ltd. has Set Ex-Dividend for November 21, 2017
Starting November 21, 2017, Camtek Ltd. (NASDAQ:$CAMT) will begin trading ex-dividend, with a cash dividend payment of $0.28 per share scheduled to be paid on November 30, 2017. Those shareholders who purchased Camtek stock before ... [Read]
Health
A Look at Anavex Life Sciences Corp.’s Current Standings
Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The company’s lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX2-73 with donepezil, ANAVEX 19-144, ANAVEX ... [Read]
NASDAQ
Axcelis Technologies Continues Strong Growth Post 3Q17 Report Release
Axcelis Technologies (NASDAQ:$ACLS) shares climbed 20.3% in October. The big gains appear to correspond with news of the semiconductor equipment company’s addition to the S&P SmallCap 600. On October 11th, the company announced that it ... [Read]
Health
Impax Laboratories Inc. Plunges 5.74% During Monday Trading
As of Monday trading on November 13th, Impax Laboratories Inc. (NASDAQ:$IPXL) plunged a cool 5.74%, or a loss of $-1.05 per share, to close at $17.25. Impax Laboratories is a pharmaceutical company, developing and commercializing ... [Read]
Biotechnology
A Closer Look at Iovance Biotherapeutics Inc.’s Recent Trading Lows
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) recently had a low trading volume day. The volume for the company on November 13th was recorded to 0.39 million contracts. Over the past three months, the average daily trading volume ... [Read]
Energy
Why You Shouldn’t be Fooled By SunPower Corp.’s Ostensibly Promising Q3 Results
Despite SunPower Corp. (NASDAQ:$SPWR) beating consensus, investors remain skeptical on the company’s profitability. Specifically, SunPower posted strong Q3 results due to earlier-than-expected completion of several projects. When it comes to project companies, however, this type ... [Read]
Insider Trading
Xcerra Corp. VP Sells 50,000 Shares, Amidst Stagnant Shares
Xcerra Corp. (NASDAQ:$XCRA) have been trending negatively for the past week. Let’s take a look at the numbers. The company itself is a provider of test and handling capital equipment, interface products, test fixtures, and ... [Read]
Healthcare
Anavex Life Sciences Corp. Releases New Clinical Data of Investigational Alzheimer’s Drug
Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including Alzheimer’s disease, other central nervous systems (CNS) diseases, pain and various types of ... [Read]
Drugs
Current Wall Street Outlooks on Impax Laboratories, Inc.
Following the Food and Drug Administration’s approval of its latest generic Renvela drug last week, Impax Laboratories, Inc. (NASDAQ:$IPXL) shares rose 5.7% to $21.50. The company indicated that sales of the sevelamer carbonate, the generic ... [Read]
Consumer
What to Expect From Rent-A-Center, Inc.’s 3Q17 Earnings Report
Rent-A-Center, Inc. (NASDAQ:$RCII) is scheduled to release 3Q17 results on Oct 30th. What should you expect? Can the rent-to-own store operator post live up to expectations? Let’s take a look. Analysts speculate Rent-A-Center shares to ... [Read]